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ABSTRACT
The membrane glycoproteins CD4 (L3T4) and CD8
(Lyt2) are expressed on distinct populations of mature
murine T lymphocytes, and are thought to be receptors
for monomorphic determinants expressed on MHC
class II and class I molecules, respectively. Although
they differin theirligand specificity, it has been pre-
sumed that CD4 and CD8 perform equivalent functions
in the T cells that bear them. Since activation of pro-
tein kinase C (PKC) is known to cause rapid down-
regulation of various receptors, including the T cell
receptor complex (TcR complex), we treated cells with
phorbol 12-myristate 13-acetate (PMA), a PKC activa-
tor, to determine whether cell-surface expression of
CD4 and CD8 would be similarly affected by this intra-
cellular mediator. Brief or relatively prolonged treat-
ment with PMA induced mature murine T cells to
reduce their surface expression of the TcR complex and
of CD4, but not of CD8. Similarly, PMA rapidly in-
duced transfected L cells to down-regulate surface
CD4 expression, but had no effect on surface CD8 ex-
pression. Most significantly, PMA treatment induced
CD4CD84 immature thymocytes to rapidly reduce their
surfaceCD4 expression, but, again, it had no immediate
effect on the surface expression of CD8. These results in-
dicate that CD4 and TcR complex cell-surface expression
are both sensitive to PKC activation by brief treatment
with PMA, whereas CD8 expression isnot, and suggest
that CD4 and CD8 surface expression levels are regu-
lated by distinct intracellular mechanisms.- KALDJIAN,
E.; MCCARTHY. S. A.; SHARROw, S. 0.; LITrMAN, D. R.;
KLAUSNER, R. D.; SINGER, A. Nonequivalent effectsof
PKS activation by PMA on murine CD4 and CD8 cell
surface expression. FASEBJ 2: 2801-2806; 1988.
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CD4 AND CD8 ARE MEMBRANE glycoproteins expressed
on separate populations of peripheral murine T lym-
phocytes, and are thought to be functionally important
in T cell activation. The CD4CD8 and CD4CD8
phenotypes correlate with T cell specificity: CD4 cells
are restricted to MHC3 class II recognition, whereas
CD8 cells are predominantly restricted to recognition
of MHC class I, and most T cell functions can be
blocked by antibodies directed against CD4 or CD8 (1).
These observations have led to two families of models
of how CD4 and CD8 function. Avidity models postulate
that CD4 and CD8 bind to MHC class II and class I
molecules, respectively, to increase the avidity of the
T cell for antigen-bearing cells (1-4), although signaling
models propose that CD4- and CD8-mediated signals
regulate the signal transduced via the T cell receptor
(5-8). These two models are not necessarily mutually
exclusive, and both imply that CD4 and CD8 may act
as functional cell-surface receptors.
In several receptor signaling systems, engagement of
the receptor triggers hydrolysis of polyphosphoinosi-
tidesto phosphoinositols and diacyl glycerol (reviewed
in ref 9). The diacyl glycerol produced by this reaction
results in the activation of PKC, which (in addition to
other intracellular events) may mediate cellular re-
sponses to extracellular stimuli. PKC activation can
also lead to the down-regulation of a variety of surface
receptors, possibly by phosphorylation of the receptors
themselves. Activation of PKC directly by the diacyl
glycerol analog PMA can mimic receptor-mediated sig-
naling in these systems and cause phosphorylation, in-
ternalization, and down-regulation of surface receptors.
For example, both murine (10) and human (11, 12)
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T cell receptor/T3 complex (TcR complex) compo-
nents are known to respond to PMA by internalization
and down-regulation of cell-surface expression.
Reduction of cell surface human CD4 (12-16) and
murine thymic CD4 (17, 18) expression on exposure to
PMA and related phorbol esters has also been reported.
Most of those studies were complicated, however, by
their relatively long time courses, and could reflect
additional, later differentiative events induced by
PMA. More recently, human CD4 (16, 19) and CD8
(16, 20) molecules have been shown to undergo rapid
phosphorylation in response to brief PMA treatment,
which suggests that these molecules are affected by
PKC activation. In this study, we therefore compared
the effects of brief and relatively prolonged PMA
exposure on cell-surface expression of murine CD4 and
CD8 on mature peripheral T cells, immature thymic
T cells,and L cell transfectants to determine whether
expression of these T cell differentiation antigens is
regulated equivalently by PMA-induced PKC activation.
MATERIALS AND METHODS
Mice
C57BL/6J (B6), C57BL/lOSnJ (BlO), and DBA/2J
mice were obtained from The Jackson Laboratory in
Bar Harbor, Maine. BlO nu/nu (nude) mice were ob-
tained from the Small Animal Section, National Insti-
tutes of Health (NIH) in Bethesda, MD.
Antibodies
53-6.72 rat anti-CD8 (anti-Lyt2) and 3.155 rat anti-
CD8 (anti-Lyt2) were obtained from the American
Type Culture Collection (Rockville, MD). 53-5.83 rat
anti-CD8 (anti-Lyt3) was provided by Dr. G. Nolan
of Stanford University (Stanford, CA). GK1.5 rat
anti-CD4 (anti-L3T4) was provided by Dr. F. Fitch,
University of Chicago (Chicago, IL). RL-172/4 rat
anti-CD4 (anti-L3T4) was provided by Dr. A. Kruis-
beek, NIH. KJ16-113.18 rat anti-Vf38 T cell receptor
was provided by Drs. J. Kappler and P. Marrack
of Denver, CO. 145-2C11 Armenian hamster anti-T3
(21) was a gift from Dr. J. Bluestone, NIH. 2.4G2 rat
anti-Fc receptor was generously provided by Ms. J. Titus,
NIH. FITC conjugates of 53-6.72 anti-CD8 and MAR
18.5 (mouse anti-rat kappa chain) antibodies were ob-
tained from Becton Dickinson Immunocytometry Sys-
tems (Mountain View, CA). FITC-GAM (goat anti-
mouse Ig) was from Boehringer Mannheim (Indi-
anapolis, IN). FITC-20-8-4 antiKb, Qa was provided
by Dr. D. Sachs, NIH, and was purified and conjugated
in our laboratory. FITC-H129.19 and biotin-conjugated
H129.19 anti-CD4 antibodies were the gifts of Ms.
J. Titus. Texas red-conjugated streptavidin was from
Bethesda Research Laboratories (Gaithersburg, MD).
Secondary mixed leukocyte culture (MLC)
supernatant
Secondary MLC supernatant was the conditioned
medium collected from a B6 anti-DBA/2J secondary
sensitization culture after 24 h, and was used in culture
at a final concentration of 20-25%.
Enrichment and culture of T cells
Spleen cells were passed over nylon wool and the
nonadherent cells were collected and counted. For
depletion of CD4 cells, nylon wool nonadherent spleen
cells were treated with RL-172/4 anti-CD4 mAb and
rabbit C. 4 x 106 cells were cultured in 2 ml of com-
plete culture medium (RPM! 1640 plus 10% FCS) sup-
plemented with secondary MLC supernatant. These
cells were cultured overnight, harvested, and prepared
for PMA treatment. Fresh thymocytes were prepared
for use immediately before PMA treatment.
L cells
L cells transfected with genomic CD4 (L3T4) DNA
(22) or genomic CD8 (Lyt2) DNA (23) have been re-
ported previously.
PMA treatment of cells
A single cell suspension at I x 106 cells/ml was treated
with 10 or 100 ng/ml PMA (Sigma, St. Louis, MO) for
the indicated times at 37#{176}Cin 5% CO2. Cells were im-
mediately washed in cold-staining medium (HBSS
without phenol red plus 0.1% BSA and 0.1% sodium
azide, 4#{176}C)and stained. PMA was stored at - 20#{176}Cin
DMSO at 5 &g/ml or in ethanol at 100 ig/ml. Control
and experimental groups were handled identically except
for PMA treatment. Cells treated with solvent alone at
the same concentration as for PMA treatment had
staining patterns identical to those of untreated cells
(data not shown).
Antibody-induced down-modulation of CD4 and CD8
Cultures of 3-4 x 106 nylon wool nonadherent BlO T
cells and 1.5-2 x 106 BlO nude spleen cells were estab-
lished in 2.5 ml culture medium (as above) containing
20% secondary MLC supernatant. Where indicated,
GKI.5 anti-CD4 mAb or 53-6.72 anti-CD8 mAb was
added to the cultures at a final concentration of 20%.
Cultures were incubated at 37#{176}Cin 7.5% CO2 for 3
days, when cells were harvested and prepared for flow
cytometric analysis.
Flow cytometry
Cells were stained by standard procedures and analyzed
for fluorescence intensity on a modified FACS II (Becton
Dickinson Immunocytometry Systems, Mountain View,
CA) (24). L cell and thymocyte stains were preceded by
resuspension in 2.4G2 anti-Fc receptor mAb to reduce
Fc-mediated nonspecific staining. Fluorescence data
were collected using logarithmic amplification on
4-5 x i0 viable cells, as determined by forward light
scatter and propidium iodide exclusion. Amplification
was provided by a 3-decade logarithmic amplifier con-
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structed from an NIH-modified design of R. Hiebert,
Los Alamos Scientific Laboratories (Los Alamos, NM).
For quantitative comparisons, median channel values
of logarithmic fluorescence for positive subpopulations
were converted to linear units with an empirically
derived standard calibration curve. The effect of PMA
treatment on fluorescence intensity was then defined as
(linear units of PMA-treated cells - linear units of
control cells)/linear units of control cells. Antibodies
and staining reagents were used at concentrations pre-
viously shown to be saturating.
RESULTS AND DISCUSSION
To determine whether cell surface expression of the
accessory molecules CD4 and CD8 is affected by PMA-
induced PKC activation, B6 nylon wool-purified splenic
T cells were pulsed with PMA for 15 mm, or left un-
treated, and then examined for cell-surface antigen ex-
pression by immunofluorescence and flow cytometry.
As expected, cell surface expression of molecules in the
TcR complex (T3 and TcR) was significantly reduced
after 15-mm exposure to PMA (Fig. 1, C and D),
whereas MHC class I (H2Kb) expression was not
(Fig. 1E). As with the TcR complex, CD4 surface ex-
pression was significantly reduced by PMA treatment
(Fig. IA); in contrast, CD8 surface expression was not
reduced (Fig. 1B). Quantitative estimates of the altera-
tions in cell surface expression of these molecules are
presented in the figure legend.
A possible explanation for the dichotomy between
the down-regulation of CD4 cell-surface expression and
the lack of down-regulation of CD8 cell-surface expres-
sion after brief PMA treatment was that PMA had no
effect on the expression of any cell-surface molecules on
CD8 cells. To test this possibility, CD4 -depleted
splenic T cells (containing predominantly CD8 T cells)
were treated with PMA for 15 mm, or left untreated,
and analyzed (Fig. 1, F andJ). These cells did exhibit
down-regulation of their cell-surface TcR complex (Fig. 1,
H and I), but did not reduce their surface expression
of CD8 (Fig. 1G). Therefore, mature CD8 cells are
responsive to the immediate effects of PKC activation
by PMA, but cell-surface expression of CD8 molecules
on these cells is not.
We therefore treated nylon wool-purified splenic
T cells with a higher concentration of PMA, over an
extended time, to determine whether cell-surface ex-
pression of CD8 on mature T cells could be regulated
by PKC activation. Figure 2 ith.istrates that cell-surface
CD8 expression, as measured by either anti-Lyt2 mAb
(a different mAb than that used in Fig. 1) or anti-Lyt3
mAb, was not reduced by PMA treatment (Fig. 2,
E-L). CD4 cell-surface expression, in contrast, was
rapidly and progressively reduced by the same treat-
ment (Fig. 2, A-D). These results, from a heteroge-
neous population of normal T cells, extend a similar
observation based on a highly unusual CD4CD8
T cell clone (16). Thus, prolongation of the PMA treat-
ment did not eliminate the dichotomy in the regulation
of CD4 and CD8 cell-surface expression on mature
T cells, but instead augmented it.
To further examine the responses of CD4 and CD8
to PMA-induced activation of PKC, L cell transfec-
tants expressing either CD4 or CD8 were pulsed with
PMA for 15 mm, or left untreated, and analyzed. We
found that L cell-surface expression of CD4 was
Figure 1. Brief PMA treatment causes down-regulation of CD4 but
not CD8 cell-surface expression on mature splenic T cells. Nylon-
purified B6 spleen cells (A-E) or nylon-purified and CD4-depleted
B6 spleen cells (F-]) were cultured overnight in medium sup-
plemented with secondary MLC supernatant. The cells were then
collected, washed, counted, and pulsed with 10 ng/ml PMA, or left
untreated, for 15 mm at 37#{176}C.The cells were then washed and
stained immediately with GK1.5 anti-CD4 (anti-L3T4) mAb and
FITC-MAR 18.5 (A and F), 53-6.72 anti-CD8 (anti-Lyt2) mAb
and FITC-MAR 18.5 (B and C), l45-2Cll anti-T3 mAb and Flit-
GAM (C and H), KJ16 anti-V138 T cell receptor and Flit-MAR
18.5 (D and I), or FITC-20-8-4 anti-K”, Qa (E and J), and then
analyzed by flow cytometry. Solid lines indicate untreated cells,
dotted lines indicate PMA-treated cells. The quantitative effects of
PMA treatment (see Materials and Methods) on fluorescence in-
tensity in each panel (relative fluorescence of dotted lines to solid
lines as measured by peak medians) are as follows: A) -28%;
B) +1%; C) -37%; D) -34%; E) -4%; (Fshows CD4 cell deple-
tion); C) -4%; H) -32%; 1) -37%; and]) +9%. (The high
fluorescence intensity shoulders in C and H were due to residual
B cells that were stained brightly by FITC-GAM alone, and were
not included in quantitative analysis.) Freshly prepared (uncul-
tured) nylon-purified spleen cells demonstrated the same dichotomy
in the effects of brief PMA treatment on CD4 and CD8 cell-surface
expression as did the cultured cells used here (data not shown).
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Figure 2. Kinetics of CD4 and CD8 cell-surface expression in
response to PMA treatment. Nylon-purified BlO spleen cells were
cultured overnight in medium supplemented with secondary MLC
supernatant. The cells were then collected, washed, counted, and
left untreated or pulsed with 100 ng/ml PMA for 15 mm, 1, 2, or
5 h at 37#{176}C.The cells were then washed and stained immediately
with RL-l72/4 anti-CD4 (anti-L3T4) mAb and Flit-MAR 18.5
(A-D), 3.155 anti-CD8 (anti-Lyt2) mAb, and Flit-MAR 18.5
(E-H), or 53-5.83 anti-CD8 (anti-Lyt3) mAb and Flit-MAR 18.5
(I-L) and then analyzed by flow cytometry. Solid lines indicate un-
treated cells; dotted lines indicate PMA-treated cells. The quantita-
tive effects of PMA treatment on fluorescence intensity in each
panel (relative fluorescence of dotted lines to solid lines as measured
by peak medians) are as follows: A) -39%; B) -61%; C) -70%;
D) -79%; E) +7%; F) +10%; G) +12%; H) +7%; I) +11%;
J) +14%; K) +14%, and L) +3%.
reduced in response to PMA, whereas L cell surface ex-
pression of CD8 was not (Fig. 3). This result indicated
that the effects of PMA on CD4 and CD8 surface ex-
pression levels in fibroblasts are similar to those in
T cells. In addition, the ability of PMA to down-
regulate cell-surface expression of CD4 on L cells
demonstrates that a physical and/or functional associa-
tion of CD4 and the TcR complex, which has recently
been proposed (25), is not required for down-regulation
of CD4 surface expression in response to PKC activation.
The murine thymus contains a population of cells ex-
pressing both CD4 and CD8. We utilized two-color im-
munofluorescence and flow cytometry to examine the
immediate and prolonged effects of PMA-induced
PKC activation on cell-surface expression of CD4 and
CD8 on such immature double positive cells. First,
fresh thymocytes were pulsed with PMA for 15 mm or
left untreated, stained for CD4 in red and for CD8 in
green, and analyzed. Figure 4 (a two-color flow cytom-
etry plot) shows the effect of this PMA treatment on
thymic-surface expression of CD4 and CD8. Single
positive CD4CD8 thymocytes responded to brief
PMA treatment in the same way as did their mature
splenic T cell counterparts in that PKC activation
reduced cell surface expression of CD4 (Fig. 4). Most
important, after brief PMA treatment, double positive
CD4CD84 thymocytes also exhibited reduced surface
CD4 expression, but had unaltered surface expression
Figure 3. L cells transfected with CD4 (L3T4) DNA down-regulate
CD4 cell-surface expression whereas L cells transfected with CD8
(Lyt2) DNA do not alter CD8 cell surface levels in response to brief
PMA treatment. CD4- and CD8-transfected L cells were pulsed
with 100 ng/ml PMA, or left untreated, for 15 mm at 37#{176}C,then
immediately washed and stained. CD4-transfected L cells were
stained with FITC-anti-CD4 (A). CD8-transfected L cells were
stained with FIit-anti-CD8 (B). Solid lines indicate untreated
cells; dotted lines indicate PMA-treated cells. The effects of PMA
treatment on fluorescence intensity in each panel are as follows:
A) -67%; B) +4%.
of CD8 (Fig. 4). On prolonged exposure of thymocytes
to PMA (Table 1), cell-surface expression of CD8 was
marginally reduced, as has been previously reported
(18). This reduction was exhibited by immature double
positive thymocytes (data not shown), which represent
the vast majority of the CD8 cells in the thymus. The
significant time lag before the onset of CD8 down-
regulation by these cells may reflect subsequent intra-
cellular signals rather than PKC activation per se. In
contrast, CD4 cell-surface expression underwent rapid
and progressive reduction in response to PKC activation
by PMA (Table 1). Inasmuch as CD4 and CD8 were
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Figure 4. Brief PMA treatment causes down-regulation of CD4 but
not CD8 cell-surface expression on CD4CD8 thymocytes. Fresh
BlO thymocytes were pulsed with 100 ng/ml PMA (B) or left un-
treated (A) for 15 mm at 37#{176}C,immediately washed and stained
with FITC-anti-CD8 and biotin-anti-CD4 plus Texas red-avidm,
and then analyzed by two-color flow cytometry. Two-color im-
munofluorescence data are plotted as increasing intensities of green
(Flit) fluorescence vs. increasing intensities of red (Texas red)
fluorescence. Constant values of total cell number were selected to
draw the rings or contours around peaks of cells correlating green
and red fluorescence. The perpendicular reference lines are in-
tended as a visual aid and were drawn to intersect at the peak of
the CD4CD8 population of untreated thymocytes. Thymocytes
treated with DMSO, the PMA solvent, at the same concentration
as for PMA treatment, stained identically to untreated thymocytes
(data not shown).
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TABLE 1. Thymic CD4 and CD8 show quantitative and kinetic differences in response to PMA
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PMA dose, ng/ml Duration of PMA treatmenta
Effect of PMA treatmen t on fluor escence intensityt
CD4 CD8
10 15mm -36% +2%
10 lh -73% +15%
10
10
3h
6h
-92%
-93%
+3%
-26%
100 15mm -17% +10%
100 lh -63% +12%
100 3h -90% -6%
100 6h -93% -31%
Fresh B6 thymocytes were incubated for 6 h in medium. At the indicated times before the completion of the incubation, PMA was added. The
cells were then stained and analyzed by flow cytometry as described in Materials and Methods. bThe quantitative effect of PMA treatment on CD4
and CD8 cell-surface expression was calculated as described in Materials and Methods.
coexpressed on the same cells in this population, the
nonequivalent effects of PMA-induced PKC activation
on CD4 and CD8 surface levels was a characteristic of
the molecules themselves, and was not caused by differ-
ences in the response to PMA of the cells bearing these
molecules.
Finally, we wished to rule out the possibility that
CD8 molecules were inherently unable to undergo ex-
tensive reduction in surface expression by any means.
Figure 5 shows that surface expression of CD8, as well
as CD4, was dramatically reduced by antibody-mediated
cross-linking. When nylon-purified splenic T cells were
cultured for 3 days with anti-CD4 or anti-CD8 antibody
in the presence of BlO nude spleen cells, as a source of
Fc receptor-bearing accessory cells to augment antibody-
mediated cross-linking, cell-surface expression of both
CD8 and CD4, monitored by indirect staining, was
markedly reduced.
One clearly described effect of PMA is the rapid acti-
vation of intracellular PKC (9). PKC, in turn, phos-
phorylates cytoplasmic residuesand increasesthe endo-
cytic internalization rates of many receptor molecules,
which results in immediate reductions in the numbers
of these molecules expressed on the cell surface (10, 11,
400
Figure 5. CD8 as well as CD4 cell-surface expression can be down-
regulated by antibody-mediated cross-linking. Nylon-purified BlO
spleen cells were cultured for 3 days in medium supplemented with
secondary MLC supernatant in the presence of BlO nude spleen
cells with or without CK1.5 anti-CD4 mAb (A) and with or without
53-6.72 anti-CD8 mAb (B). Cells were harvested, counted, and
stained with GK1.5 mAb and Flit-MAR 18.5 (A), or 53-6.72 mAb
and Flit-MAR 18.5 (B), and then analyzed by flow cytometry.
Solid lines indicate cells cultured without mAb; dotted lines indi-
cate cells cultured with mAb. The quantitative effects of antibody
in culture on fluorescence intensity are as follows: A) -87%;
B) -82%.
19). However, the relationship between phosphorylation
and internalization of cell-surface receptor molecules is
not obligatory (26-28), and, in fact, the effect of phorbol
esters on receptor redistribution may be the result of
the phosphorylation of nonreceptor elements involved
in membrane trafficking. Indeed, PKC phosphorylates
cytoplasmic residues on human CD4 (16, 19) and human
CD8 (16, 20) molecules, and may phosphorylate
cytoplasmic residues on both murine CD4 and CD8 as
well. Thus, the present observation that PMA-induced
activation of PKC rapidly down-regulates cell surface
expression of murine CD4, but not murine CD8, was
unexpected and is of special interest. The differential
effects of prolonged PMA treatment on CD8 cell-
surface expression in mature CD4CD8 and immature
CD4CD8 T cellsalso merits further analysis.
Although PMA-induced PKC activation does not
always mimic ligand engagement (27, 28), the striking
disparity in the behavior of murine CD4 and CD8 on
exposure to PMA in each experimental system we have
studied indicates that the regulation of cell-surface ex-
pression of CD4 and CD8 molecules can be distin-
guished from each other. Consequently, this study
raises questions about the presumption that CD4 and
CD8 are functionally equivalent molecules that differ
only in their ligand specificity.
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